Company Filing History:
Years Active: 2012-2014
Title: The Innovations of Philip Wickens
Introduction
Philip Wickens is a notable inventor based in Richmond Hill, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. With a total of 3 patents to his name, Wickens has focused on innovative solutions for complex medical challenges.
Latest Patents
Wickens' latest patents include groundbreaking work on heteroaryl substituted pyrazole derivatives. These compounds are useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds, and their use for treating hyper-proliferative and/or angiogenesis disorders, either as a sole agent or in combination with other active ingredients or therapeutic measures. Another significant patent involves pyrrolotriazine derivatives, which are useful for treating cancer through the inhibition of aurora kinase. This invention encompasses novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, especially cancer.
Career Highlights
Throughout his career, Wickens has worked with prominent companies in the pharmaceutical industry, including Bayer Healthcare LLC and Bayer Intellectual Property GmbH. His work has contributed to advancements in medical treatments and has positioned him as a key figure in pharmaceutical innovation.
Collaborations
Wickens has collaborated with esteemed colleagues such as Steven R. Magnuson and Zhonghua Zhang. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.
Conclusion
Philip Wickens is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.